Skip to content

Acute Effects of Dairy and Meat Proteins on Bone Metabolism and Metabolic Profile

Acute Effects of Dairy and Meat Proteins on Bone Metabolism and Metabolic Profile in Urine and Plasma in Overweight Adults

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01773304
Acronym
MEDA
Enrollment
17
Registered
2013-01-23
Start date
2012-12-31
Completion date
2013-02-28
Last updated
2013-03-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bone Metabolism, Obesity

Keywords

Obesity, Adults, Bone metabolism, Metabolic profile, Dairy protein, Meat protein

Brief summary

The purpose of this randomized, controlled, cross over single meal study is to investigate the metabolic effects of a breakfast rich in dairy proteins and to determine biomarkers for their intake. The results from this project will increase our knowledge about nutritional value of dairy proteins, which is necessary to decide whether dairy products can be recommended for prevention of weight related bone loss.

Interventions

Test meals with different protein types (dairy versus meat)

Sponsors

Danish Agriculture and Food Council
CollaboratorOTHER
University of Copenhagen
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 50 Years
Healthy volunteers
Yes

Inclusion criteria

* Healthy males and females between 18 and 50 years * BMI 25-40

Exclusion criteria

* Physical activity more than 10 hours weekly * Smoking * Diagnosed osteoporosis in at least one parent * Dietary supplements and vitamin pills (during the study and 2 months before the start) * Vegetarians and vegans * Lactose intolerant * Women who are pregnant, breastfeeding or post-menstrual * Regular intake of medication * Chronic diseases (including osteoporosis, cancer, diabetes, cardiovascular disease and mental disorders) * Participation in other clinical trials that could affect the test results * Donation of blod within 3 months before intervention start * Hypersensitivity to paraaminobenzoic acid (PABA) * Not able to comply with the procedures established by the Protocol

Design outcomes

Primary

MeasureTime frame
plasma metabolites for metabolomics analysesat 0, 30, 60, 120, 180 and 240 min at both visits
urine metabolites for metabolomics analysesbaseline 24-h urine samples, 24-h urine samples after the meal test, urine samples at 2-h and 4-h after the meal test and urine samples from 4-h to 24-h, all at both visits
serum C-terminal carboxy-terminal collagen crosslinks (CTX)at 0, 30, 60, 120, 180 and 240 min at both visits
urine C-terminal carboxy-terminal collagenbaseline 24-h urine samples and 24-h urine samples after the meal test at both visits
serum osteocalcin (sOC)at 0, 30, 60, 120, 180 and 240 min at both visits
serum tartrate-resistant acid phosphatase (s-TRAP)at 0, 30, 60, 120, 180 and 240 min at both visits
urine deoxypyridinoline crosslink (uDPD)baseline 24-h urine samples and 24-h urine samples after the meal test at both visits

Secondary

MeasureTime frame
urinary creatininbaseline 24-h urine samples and 24-h urine samples after the meal test at both visits
plasma biobankat 0, 30, 60, 90, 120, 180 and 240 min at both visits
urinary biobankbaseline 24-h urine samples and 24-h urine samples after the meal test at both visits
serum insulin-growth factor-1 (IGF-1)at 0, 30, 60, 120, 180 and 240 min at both visits
serum insulin-growth factor binding-protein-3 (IGFBP-3)at 0, 30, 60, 120, 180 and 240 min at both visits
serum insulinat 0, 30, 60, 120, 180 and 240 min at both visits
serum glucoseat 0, 30, 60, 120, 180 and 240 min at both visits
serum glukagon-like peptide-1 (GLP-1)at 0, 30, 60, 120, 180 and 240 min at both visits
urinary PABAbaseline 24-h urine samples and 24-h urine samples after the meal test at both visits

Other

MeasureTime frame
weightat baseline at both visits
heightat baseline at the first visit

Countries

Denmark

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026